newsfilter
← Latest News
GlobeNewswire·

NeuBase Therapeutics Reports Financial Results for the Third Quarter of Fiscal Year 2021 and Recent Operating Highlights

Further demonstrated broad potential of novel genetic medicine platform with in vivo data in three diseases driven by different genetic mechanisms of disease Presented preclinical data showing compounds enabled with NeuBase's proprietary delivery techn